Copyright Reports & Markets. All rights reserved.

Global Lysosomal Storage Diseases Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Lysosomal Storage Diseases Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Lysosomal Storage Diseases Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Enzyme Replacement Therapy
    • 1.4.3 Substrate Reduction Therapy
    • 1.4.4 Cystine Depleting Agents
  • 1.5 Market by Application
    • 1.5.1 Global Lysosomal Storage Diseases Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Ambulatory Surgical Centers
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Lysosomal Storage Diseases Market Perspective (2015-2026)
  • 2.2 Global Lysosomal Storage Diseases Growth Trends by Regions
    • 2.2.1 Lysosomal Storage Diseases Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Lysosomal Storage Diseases Historic Market Share by Regions (2015-2020)
    • 2.2.3 Lysosomal Storage Diseases Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Lysosomal Storage Diseases Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Lysosomal Storage Diseases Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Lysosomal Storage Diseases Players by Market Size
    • 3.1.1 Global Top Lysosomal Storage Diseases Players by Revenue (2015-2020)
    • 3.1.2 Global Lysosomal Storage Diseases Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Lysosomal Storage Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Lysosomal Storage Diseases Market Concentration Ratio
    • 3.2.1 Global Lysosomal Storage Diseases Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Lysosomal Storage Diseases Revenue in 2019
  • 3.3 Lysosomal Storage Diseases Key Players Head office and Area Served
  • 3.4 Key Players Lysosomal Storage Diseases Product Solution and Service
  • 3.5 Date of Enter into Lysosomal Storage Diseases Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Lysosomal Storage Diseases Historic Market Size by Type (2015-2020)
  • 4.2 Global Lysosomal Storage Diseases Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Lysosomal Storage Diseases Market Size by Application (2015-2020)
  • 5.2 Global Lysosomal Storage Diseases Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Lysosomal Storage Diseases Market Size (2015-2020)
  • 6.2 Lysosomal Storage Diseases Key Players in North America (2019-2020)
  • 6.3 North America Lysosomal Storage Diseases Market Size by Type (2015-2020)
  • 6.4 North America Lysosomal Storage Diseases Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Lysosomal Storage Diseases Market Size (2015-2020)
  • 7.2 Lysosomal Storage Diseases Key Players in Europe (2019-2020)
  • 7.3 Europe Lysosomal Storage Diseases Market Size by Type (2015-2020)
  • 7.4 Europe Lysosomal Storage Diseases Market Size by Application (2015-2020)

8 China

  • 8.1 China Lysosomal Storage Diseases Market Size (2015-2020)
  • 8.2 Lysosomal Storage Diseases Key Players in China (2019-2020)
  • 8.3 China Lysosomal Storage Diseases Market Size by Type (2015-2020)
  • 8.4 China Lysosomal Storage Diseases Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Lysosomal Storage Diseases Market Size (2015-2020)
  • 9.2 Lysosomal Storage Diseases Key Players in Japan (2019-2020)
  • 9.3 Japan Lysosomal Storage Diseases Market Size by Type (2015-2020)
  • 9.4 Japan Lysosomal Storage Diseases Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Lysosomal Storage Diseases Market Size (2015-2020)
  • 10.2 Lysosomal Storage Diseases Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Lysosomal Storage Diseases Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Lysosomal Storage Diseases Market Size by Application (2015-2020)

11 India

  • 11.1 India Lysosomal Storage Diseases Market Size (2015-2020)
  • 11.2 Lysosomal Storage Diseases Key Players in India (2019-2020)
  • 11.3 India Lysosomal Storage Diseases Market Size by Type (2015-2020)
  • 11.4 India Lysosomal Storage Diseases Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Lysosomal Storage Diseases Market Size (2015-2020)
  • 12.2 Lysosomal Storage Diseases Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Lysosomal Storage Diseases Market Size by Type (2015-2020)
  • 12.4 Central & South America Lysosomal Storage Diseases Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Actelion Pharmaceuticals
    • 13.1.1 Actelion Pharmaceuticals Company Details
    • 13.1.2 Actelion Pharmaceuticals Business Overview
    • 13.1.3 Actelion Pharmaceuticals Lysosomal Storage Diseases Introduction
    • 13.1.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2015-2020))
    • 13.1.5 Actelion Pharmaceuticals Recent Development
  • 13.2 BioMarin
    • 13.2.1 BioMarin Company Details
    • 13.2.2 BioMarin Business Overview
    • 13.2.3 BioMarin Lysosomal Storage Diseases Introduction
    • 13.2.4 BioMarin Revenue in Lysosomal Storage Diseases Business (2015-2020)
    • 13.2.5 BioMarin Recent Development
  • 13.3 Genzyme
    • 13.3.1 Genzyme Company Details
    • 13.3.2 Genzyme Business Overview
    • 13.3.3 Genzyme Lysosomal Storage Diseases Introduction
    • 13.3.4 Genzyme Revenue in Lysosomal Storage Diseases Business (2015-2020)
    • 13.3.5 Genzyme Recent Development
  • 13.4 Takeda
    • 13.4.1 Takeda Company Details
    • 13.4.2 Takeda Business Overview
    • 13.4.3 Takeda Lysosomal Storage Diseases Introduction
    • 13.4.4 Takeda Revenue in Lysosomal Storage Diseases Business (2015-2020)
    • 13.4.5 Takeda Recent Development
  • 13.5 Alexion Pharmaceuticals
    • 13.5.1 Alexion Pharmaceuticals Company Details
    • 13.5.2 Alexion Pharmaceuticals Business Overview
    • 13.5.3 Alexion Pharmaceuticals Lysosomal Storage Diseases Introduction
    • 13.5.4 Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2015-2020)
    • 13.5.5 Alexion Pharmaceuticals Recent Development
  • 13.6 Amicus Therapeutics
    • 13.6.1 Amicus Therapeutics Company Details
    • 13.6.2 Amicus Therapeutics Business Overview
    • 13.6.3 Amicus Therapeutics Lysosomal Storage Diseases Introduction
    • 13.6.4 Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2015-2020)
    • 13.6.5 Amicus Therapeutics Recent Development
  • 13.7 Chiesi Farmaceutici
    • 13.7.1 Chiesi Farmaceutici Company Details
    • 13.7.2 Chiesi Farmaceutici Business Overview
    • 13.7.3 Chiesi Farmaceutici Lysosomal Storage Diseases Introduction
    • 13.7.4 Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2015-2020)
    • 13.7.5 Chiesi Farmaceutici Recent Development
  • 13.8 Greenovation Biotech And FGK Clinical Research
    • 13.8.1 Greenovation Biotech And FGK Clinical Research Company Details
    • 13.8.2 Greenovation Biotech And FGK Clinical Research Business Overview
    • 13.8.3 Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Introduction
    • 13.8.4 Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2015-2020)
    • 13.8.5 Greenovation Biotech And FGK Clinical Research Recent Development
  • 13.9 Horizon Pharma
    • 13.9.1 Horizon Pharma Company Details
    • 13.9.2 Horizon Pharma Business Overview
    • 13.9.3 Horizon Pharma Lysosomal Storage Diseases Introduction
    • 13.9.4 Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2015-2020)
    • 13.9.5 Horizon Pharma Recent Development
  • 13.10 Leadiant Biosciences
    • 13.10.1 Leadiant Biosciences Company Details
    • 13.10.2 Leadiant Biosciences Business Overview
    • 13.10.3 Leadiant Biosciences Lysosomal Storage Diseases Introduction
    • 13.10.4 Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2015-2020)
    • 13.10.5 Leadiant Biosciences Recent Development
  • 13.11 Mylan
    • 10.11.1 Mylan Company Details
    • 10.11.2 Mylan Business Overview
    • 10.11.3 Mylan Lysosomal Storage Diseases Introduction
    • 10.11.4 Mylan Revenue in Lysosomal Storage Diseases Business (2015-2020)
    • 10.11.5 Mylan Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Lysosomal Storage Diseases market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lysosomal Storage Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Actelion Pharmaceuticals
    BioMarin
    Genzyme
    Takeda
    Alexion Pharmaceuticals
    Amicus Therapeutics
    Chiesi Farmaceutici
    Greenovation Biotech And FGK Clinical Research
    Horizon Pharma
    Leadiant Biosciences
    Mylan

    Market segment by Type, the product can be split into
    Enzyme Replacement Therapy
    Substrate Reduction Therapy
    Cystine Depleting Agents
    Market segment by Application, split into
    Hospitals
    Ambulatory Surgical Centers

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now